The company has registered total income of Rs. 3,847 crores for Q4 FY21, up by 3% on a y-o-y basis from Rs. 3,752 crores registered during corresponding period of the previous year
Mucormycosis drug AmphoTLC will be imported from Taiwan by Stelis Biopharma Private Limited (Stelis), the biotech arm of Strides group, and will be launched and distributed in India immediately by Strides
MEK inhibitor compound (LNP3794) developed as part of its oncology pipeline had previously shown pre-clinical activity as a single agent as well as in combination
PAT increased from Rs. 10.8 crores in FY20 to Rs. 49.1 crores in FY21 and PAT margin expanded from 2% to 7.2% YoY
The company expects to bring the first of these two phases on-stream in about two years after receipt of all needed approvals
Dr. Sharvil Patel cites the example of prescriptions being handed over to patients despite unavailability of enough stock of such medicines
By using renewables instead of fossil resources alone, CO2 emissions at Uzin Utz can be reduced by nearly 3,000 tons per year in terms of raw materials
The expansion will support new brand adoptions of Naia in womenswear fashion, where there is a growing demand for sustainable fibers
Opteon XL41 is a low GWP, non-ozone depleting refrigerant that offers a 78% reduction in GWP while improving energy efficiency and lowering charge size when compared to R-410A
It is expected that the drug substance would be available from August 2021 which will be supplied back to Bharat Biotech for producing COVAXIN
EUV pellicles prevent photomasks from dust contamination and hence, contribute to better productivity in lithography processes
It reported total income of Rs.40.16 crores during the 12 months period ended March 31, 2021
GSFC has reported total income of Rs.7817.24 crores during the 12 months period ended March 31, 2021
NOCIL reported total income of Rs.939.38 crores during the 12 months period ended March 31, 2021
The company has posted net profit of Rs.9.68 crores for the 12 months period ended March 31, 2021
The company has posted net loss of Rs. (28.35) crores for the 12 months period ended March 31, 2021
There was no casualty/injury reported due to fire and the company thanked the local administration, neighbouring industries and fire brigade for their timely support
Consequently, AstraZeneca India and Sun Pharma have now discontinued the Distribution Agreement signed in 2016 and have entered into a Transition Supply Agreement with effect from 28th May 2021
The dividend will be paid June 14, 2021 to shareholders of record June 7, 2021
SK Capital plans to merge the two businesses to form a premier North American wood coatings company called Canlak Coatings
TotalEnergies - Gurin Energy selects Saft’s battery energy storage system for first Japanese project
Subscribe To Our Newsletter & Stay Updated
_195_291.jpg)
